Clozapine induced severe weight loss in resistant schizophrenia managed with risperidone add-on therapy

Please use this identifier to cite or link to this item: http://repository.kln.ac.lk/handle/123456789/22007

Full metadata record

DC Field	Value	Language
dc.contributor.author	Chandradasa, M.	-
dc.contributor.author	Kuruppuarachchi, C.S.	-
dc.contributor.author	Rathnayake, L.C.	-
dc.contributor.author	Kuruppuarachchi, K.A.L.A.	-
dc.date.accessioned	2021-02-18T09:39:45Z	-
dc.date.available	2021-02-18T09:39:45Z	-
dc.date.issued	2020	-
dc.identifier.citation	Sri Lanka Journal of Psychiatry.2020; 11(2): 38–39.	en_US
dc.identifier.issn	2579-2008	-
dc.identifier.uri	http://repository.kln.ac.lk/handle/123456789/22007	-
dc.description	Not indexed in MEDLINE	en_US
dc.description.abstract	ABSTRACT: Clozapine is prescribed for resistant schizophrenia. It is usually associated with weight gain. There have been only a few reports of weight loss associated with clozapine treatment and we report two patients from Sri Lanka. The first patient lost 27% of bodyweight on clozapine while the second lost 17%. Both were clinically stable on clozapine, with marked reduction of psychotic symptoms. Adding risperidone helped to regain the lost weight in the described patients. KEYWORDS: Clozapine, Weight, Schizophrenia, Sri Lanka	en_US
dc.language.iso	en_US	en_US
dc.publisher	Sri Lanka College of Psychiatrists	en_US
dc.subject	weight loss	en_US
dc.title	Clozapine induced severe weight loss in resistant schizophrenia managed with risperidone add-on therapy	en_US
dc.type	Article	en_US
Appears in Collections:	Journal/Magazine Articles

Files in This Item:

File	Description	Size	Format
Clozapine induced severe weight.pdf		1.07 MB	Adobe PDF	View/Open

DSpace JSPUI